Akari Therapeutics (AKTX) Institutional Ownership $4.25 +0.26 (+6.52%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Akari Therapeutics (NASDAQ:AKTX)CurrentInstitutional OwnershipPercentage5.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$88.95KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$28.50M Get AKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AKTX Institutional Buying and Selling by Quarter Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. Akari Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/5/2024Omnia Family Wealth LLC87,628$273K0.1%+48.2%1.551% 11/15/2023Sabby Management LLC178,091$703K0.5%-97.6%3.152% 11/14/2022Armistice Capital LLC4,290,000$2.70M0.0%N/A5.762% 10/27/2022Omnia Family Wealth LLC782,372$493K0.4%+3.2%1.051% 5/6/2022Omnia Family Wealth LLC758,144$910K0.6%+13.7%1.277% 4/13/2022 Hikari Power Ltd130,821$157K0.0%+45.7%0.220% Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/10/2022Wsfs Capital Management LLC100,000$150K0.1%N/A0.193% 2/4/2022Omnia Family Wealth LLC667,085$1.00M0.6%+42.8%1.285% 8/13/2021Renaissance Technologies LLC151,396$262K0.0%+14.0%0.318% 8/6/2021HighTower Advisors LLC26,000$45K0.0%N/A0.055% 8/3/2021Omnia Family Wealth LLC467,085$808K0.5%+12.1%0.981% 5/21/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/18/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/17/2021HRT Financial LP16,087$42K0.0%N/A0.101% 5/13/2021Renaissance Technologies LLC132,751$350K0.0%+23.3%0.837% 5/12/2021Geode Capital Management LLC30,264$79K0.0%N/A0.191% 5/12/2021Omnia Family Wealth LLC416,584$1.10M0.8%+6.4%2.627% 2/16/2021Endurant Capital Management LP206,561$382K0.1%N/A1.303% 2/10/2021HighTower Advisors LLC26,000$49K0.0%+62.5%0.164% 11/3/2020United Asset Strategies Inc.286,611$499K0.1%-4.5%1.807% 10/20/2020Wedbush Securities Inc.31,381$55K0.0%N/A0.198% 10/8/2020 Hikari Power Ltd89,815$156K0.0%-94.0%0.566% 8/28/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076% 8/7/2020Virtu Financial LLC18,129$40K0.0%N/A0.114% 8/7/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076% 8/3/2020United Asset Strategies Inc.300,000$654K0.1%N/A1.892% (Data available from 1/1/2016 forward) AKTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AKTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Akari Therapeutics shares: Armistice Capital LLC ($2.70M), and Sabby Management LLC ($703K), Omnia Family Wealth LLC ($273K).Learn more on AKTX's institutional investors. What percentage of Akari Therapeutics stock is owned by institutional investors? 5.06% of Akari Therapeutics stock is owned by institutional investors. Learn more on AKTX's institutional investor holdings. Which institutional investors have been buying Akari Therapeutics stock? The following institutional investors have purchased Akari Therapeutics stock in the last 24 months: Armistice Capital LLC ($4.29M), and Omnia Family Wealth LLC ($52.74K). How much institutional buying is happening at Akari Therapeutics? Institutional investors have bought a total of 4,342,739 shares in the last 24 months. This purchase volume represents approximately $54.45M in transactions. Which Akari Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Akari Therapeutics stock in the last 24 months: Sabby Management LLC ($7.21M). How much institutional selling is happening at Akari Therapeutics? Institutional investors have sold a total of 7,214,040 shares in the last 24 months. This volume of shares sold represents approximately $28.50M in transactions. Related Companies: Oncternal Therapeutics Institutional Ownership Regulus Therapeutics Institutional Ownership Adagene Institutional Ownership Relmada Therapeutics Institutional Ownership FibroGen Institutional Ownership Coya Therapeutics Institutional Ownership Sagimet Biosciences Institutional Ownership InterCure Institutional Ownership Adicet Bio Institutional Ownership Oramed Pharmaceuticals Institutional Ownership This page (NASDAQ:AKTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.